Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

Crofelemer, a novel agent for treatment of secretory diarrhea.

Crutchley RD, Miller J, Garey KW.

Ann Pharmacother. 2010 May;44(5):878-84. doi: 10.1345/aph.1M658. Epub 2010 Apr 13. Review.

PMID:
20388859
2.

Crofelemer for the treatment of secretory diarrhea.

Cottreau J, Tucker A, Crutchley R, Garey KW.

Expert Rev Gastroenterol Hepatol. 2012 Feb;6(1):17-23. doi: 10.1586/egh.11.87. Review.

PMID:
22149578
3.

Crofelemer: In HIV Associated Diarrhea and Secretory Diarrhea - A Patent Perspective.

Biswal S.

Recent Pat Antiinfect Drug Discov. 2014;9(2):136-43. Review.

PMID:
25851117
4.
5.

Crofelemer, a novel agent for treatment of non-infectious diarrhea in HIV-infected persons.

Chordia P, MacArthur RD.

Expert Rev Gastroenterol Hepatol. 2013 Sep;7(7):591-600. doi: 10.1586/17474124.2013.832493. Review.

PMID:
24070150
6.

Crofelemer for the symptomatic relief of non-infectious diarrhea in adult patients with HIV/AIDS on anti-retroviral therapy.

Castro JG, Chin-Beckford N.

Expert Rev Clin Pharmacol. 2015;8(6):683-90. doi: 10.1586/17512433.2015.1082424. Epub 2015 Aug 27. Review.

PMID:
26517110
7.

The role of loperamide in gastrointestinal disorders.

Hanauer SB.

Rev Gastroenterol Disord. 2008 Winter;8(1):15-20. Review.

PMID:
18477966
8.

Systematic review: racecadotril in the treatment of acute diarrhoea in children.

Szajewska H, RuszczyƄski M, Chmielewska A, Wieczorek J.

Aliment Pharmacol Ther. 2007 Sep 15;26(6):807-13. Review.

9.

Management of noninfectious diarrhea associated with HIV and highly active antiretroviral therapy.

Macarthur RD.

Am J Manag Care. 2013 Sep;19(12 Suppl):s238-45. Review.

10.

Prevention and treatment of traveler's diarrhea: a clinical pharmacological approach.

Scarpignato C, Rampal P.

Chemotherapy. 1995;41 Suppl 1:48-81. Review.

PMID:
7671647
11.

[Management of patients with traveler's diarrhea].

Diridl G, Wallis E, Wolf D.

Acta Med Austriaca. 1992;19(2):58-60. Review. German.

PMID:
1509861
12.

Antimotility agents for chronic diarrhoea in people with HIV/AIDS.

Nwachukwu CE, Okebe JU.

Cochrane Database Syst Rev. 2008 Oct 8;(4):CD005644. doi: 10.1002/14651858.CD005644.pub2. Review.

PMID:
18843696
13.

Traveler's diarrhea: a clinical review.

Steffen R, Hill DR, DuPont HL.

JAMA. 2015 Jan 6;313(1):71-80. doi: 10.1001/jama.2014.17006. Review.

PMID:
25562268
14.

Review article: anti-diarrhoeal pharmacology and therapeutics.

Schiller LR.

Aliment Pharmacol Ther. 1995 Apr;9(2):87-106. Review.

PMID:
7605866
15.

Capecitabine: a review.

Walko CM, Lindley C.

Clin Ther. 2005 Jan;27(1):23-44. Review.

PMID:
15763604
16.

Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.

Evans BW, Clark WK, Moore DJ, Whorwell PJ.

Cochrane Database Syst Rev. 2007 Oct 17;(4):CD003960. Review.

PMID:
17943807
17.

Discovery and development of antisecretory drugs for treating diarrheal diseases.

Thiagarajah JR, Ko EA, Tradtrantip L, Donowitz M, Verkman AS.

Clin Gastroenterol Hepatol. 2014 Feb;12(2):204-9. doi: 10.1016/j.cgh.2013.12.001. Epub 2013 Dec 4. Review.

18.

Antidiarrheal agents for the management of treatment-related diarrhea in cancer patients.

Ippoliti C.

Am J Health Syst Pharm. 1998 Aug 1;55(15):1573-80. Review.

PMID:
9706182
19.

Clinical role of diosmectite in the management of diarrhea.

Guarino A, Lo Vecchio A, Pirozzi MR.

Expert Opin Drug Metab Toxicol. 2009 Apr;5(4):433-40. doi: 10.1517/17425250902865594 . Review.

PMID:
19379128
20.

Lubiprostone: chloride channel activator for chronic constipation.

Rivkin A, Chagan L.

Clin Ther. 2006 Dec;28(12):2008-21. Review.

PMID:
17296458

Supplemental Content

Support Center